Top worldwide anti-diabetic products by market share 2017 and 2024

Top anti-diabetic products worldwide based on market share in 2017 and 2024

Top worldwide anti-diabetic products by market share 2017 and 2024 This statistic displays the market share of top anti-diabetic products worldwide in 2017 and a projection for 2024. Novo Nordisk's Ozempic is expected to have a market share of 7.4 percent in 2024. Anti-diabetic medication is commonly ingested orally, with the exception of insulin, exenatide, liraglutide, and pramlintide. Drugs used to treat diabetes mellitus are often called oral hypoglycemic agents or oral antihyperglycemic agents.
Show more

Top anti-diabetic products worldwide based on market share in 2017 and 2024

Loading statistic...
Product (Company)20172024
Trulicity (Eli Lilly)4.4%7.8%
Ozempic (Novo Nordisk)-7.4%
Jardiance (Boehringer Ingelheim)2.5%5.9%
Tresiba (Novo Nordisk)2.4%5.7%
NovoRapid (Novo Nordisk)6.6%4.3%
Product (Company)20172024
Trulicity (Eli Lilly)4.4%7.8%
Ozempic (Novo Nordisk)-7.4%
Jardiance (Boehringer Ingelheim)2.5%5.9%
Tresiba (Novo Nordisk)2.4%5.7%
NovoRapid (Novo Nordisk)6.6%4.3%
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment

Description

Source

More information

This statistic displays the market share of top anti-diabetic products worldwide in 2017 and a projection for 2024. Novo Nordisk's Ozempic is expected to have a market share of 7.4 percent in 2024. Anti-diabetic medication is commonly ingested orally, with the exception of insulin, exenatide, liraglutide, and pramlintide. Drugs used to treat diabetes mellitus are often called oral hypoglycemic agents or oral antihyperglycemic agents.
Show more
Release date
June 2018
Region
Worldwide
Survey time period
as of May 2018
Supplementary notes
Market share based on revenue.
* Projected.
Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Diabetes
Diabetes

All Information
in one Presentation

Diabetes

Everything On "Diabetes" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Diabetes"
  • Global overview
  • Countries and regions
  • Costs
  • Diabetes care market
The most important statistics
  • Deaths
  • Outlook
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.